Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects

NCT03302182 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Ritonavir for cycle1 and NORVIR for cycle 2
DRUG: NORVIR for cycle 1 and Ritonavir for cycle 2

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

[object Object]